Cyrus Poonawalla

Cyrus Poonawalla

Personal information
Full name	Cyrus Soli Poonawalla
Nationality	Indian
Born	1941 Pune, Maharashtra, India
Occupation	Entrepreneur
Known for	Founder of Serum Institute of India
Organisation	Serum Institute of India

Cyrus Soli Poonawalla is an Indian entrepreneur. Cyrus Soli Poonawalla is an Indian entrepreneur who founded the Serum Institute of India, a vaccine manufacturer that became a major supplier to immunisation programmes around the world. This profile summarises the documented milestones of the subject’s life, work, and public contribution.

Poonawalla was born into a family associated with horse breeding and studied at Brihan Maharashtra College of Commerce in Pune. In the 1960s, he began exploring the possibility of producing affordable vaccines in India, with the aim of making preventive healthcare more accessible.

He founded the Serum Institute of India in 1966. The company initially focused on antisera and later expanded into vaccines for diseases including measles, tetanus, diphtheria, and other preventable illnesses.

Serum Institute developed manufacturing capacity and a broad vaccine portfolio, supplying products to domestic and international markets. Its scale and pricing have made it an important participant in global immunisation efforts, including programmes supported by international public-health organisations.

During the COVID-19 pandemic, Serum Institute manufactured the Covishield vaccine in India under arrangements involving the Oxford–AstraZeneca vaccine. The pandemic highlighted the importance of manufacturing capacity, supply chains, regulatory oversight, and equitable access to vaccines.

Poonawalla’s work is closely linked to vaccine production and the expansion of India’s role in global public health. The company’s contribution is measured not only by commercial growth but also by manufacturing reliability, safety standards, affordability, and the reach of immunisation programmes.

Vaccine development and distribution require collaboration among scientists, regulators, governments, and international agencies. A balanced account of the sector recognises both its public-health benefits and the need for transparent safety monitoring and equitable access.

Vaccine development and distribution require collaboration among scientists, regulators, governments, and international agencies. A balanced account of the sector recognises both its public-health benefits and the need for transparent safety monitoring and equitable access.

The subject’s career can be understood through the institutions built, the people and communities affected, and the broader changes in the relevant industry or field. Future developments, public disclosures, and independent assessments may add context to this account.

• Serum Institute of India – About Us
• Serum Institute – Products
• World Health Organization – Vaccines

1. Serum Institute of India. “Serum Institute of India – About Us”. Official information and background resources.
2. Serum Institute. “Serum Institute – Products”. Official information and background resources.
3. World Health Organization. “World Health Organization – Vaccines”. Official information and background resources.